Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Apr 12, 2024 10:19am
69 Views
Post# 35985482

It's no secret that China has vastly accelerated their R&D

It's no secret that China has vastly accelerated their R&Dwork in studying advanced cannabinoid compounds.   But why all of the sudden this surge in R&D work?  I said before, COVID taught them a very difficult lesson and avian bird flu IS a global phenomena.   

So now we can sit back and watch the stupidity of the new age roman empire politics now lagging far behind China as they prepare for the spread of the existing global pandemic into humans...avian bird flu.  

(LABS and McMaster)  >>>>Apotex>>>>>China.

Apotex opened their first location in China decades ago.  

The U.S. is now way behind the curve of avian bird flu and it will send a shock wave into the food supply chain, beef, dairy, pork, chicken, eggs. 

I hope Yellen and the U.S. Fed Chairman can manage things, inflation driven by shortages.  

2024 is already shaping up to be a very, very, interesting year.  



<< Previous
Bullboard Posts
Next >>